-
LUCE WEBINAR: ESMO 2020 LUNG CANCER HIGHLIGHTS
Lung Cancer Europe (LuCE) held a webinar on ESMO 2020 lung cancer highlights. The webinar was given by Professor Sanjay Popat FRCP PhD, Consultan Medical…
-
LUCE WEBINAR: HOW DRUG PRICES ARE DETERMINED?
Lung Cancer Europe (LuCE) held a webinar on how drug prices are determined. The webinar was given by Eric Low, owner and founder of Eric…
-
PAN-EUROPEAN SURVEY OF PATIENT PERCEPTION OF UNMET NEED AND VALUE DRIVERS IN NSCLC
A pan-European survey is being conducted with the aim to understand the following about people’s experience with non-small cell lung cancer (NSCLC), with the overall aim…
-
LUCE WEBINAR: WHAT ARE CLINICAL TRIALS AND HOW ARE THEY CONDUCTED?
Lung Cancer Europe (LuCE) held a webinar on what clinical trails are and they are conducted. The webinar was given by Saskia Litière, Head of…
-
UPCOMING LUCE WEBINAR – HOW DRUG PRICES ARE DETERMINED?
Lung Cancer Europe (LuCE) is holding a webinar on how drug prices are determined and how their value is assessed in the European countries. The…
-
WEBINAR – WHAT ARE CLINICAL TRIALS AND HOW ARE THEY CONDUCTED?
Lung Cancer Europe (LuCE) is holding a webinar on how clinical trials design covering the basic concepts around this topic: what are clinical trials, different…
-
EMOTIONAL AND SOCIAL IMPACT OF LUNG CANCER ON PATIENTS AND CAREGIVERS
Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such as access to treatment, care…
-
A WARM WELCOME TO LUCE’S NEW BOARD
LuCE’s newly elected board members as of 09/05/2020: Anne-Marie Baird – PresidentEwelina Szmytke – Vice-PresidentRegine Deniel Ihlen – TreasurerTommy Björk – Board MemberLavinia Magee –…
-
COVID 19: FAQS FOR PEOPLE WITH LUNG CANCER
The responses are for informational use only―they don’t substitute the medical advice. If you have specific questions about your own situation, please consult your treating…